ZA902282B - Selective adenosine receptor compounds - Google Patents

Selective adenosine receptor compounds

Info

Publication number
ZA902282B
ZA902282B ZA902282A ZA902282A ZA902282B ZA 902282 B ZA902282 B ZA 902282B ZA 902282 A ZA902282 A ZA 902282A ZA 902282 A ZA902282 A ZA 902282A ZA 902282 B ZA902282 B ZA 902282B
Authority
ZA
South Africa
Prior art keywords
adenosine receptor
selective adenosine
receptor compounds
compounds
selective
Prior art date
Application number
ZA902282A
Other languages
English (en)
Inventor
Norton Paul Peet
Paul Peet Norton
Nelsen Lowell Lentz
Lowell Lentz Nelsen
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA902282B publication Critical patent/ZA902282B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
ZA902282A 1989-03-29 1990-03-23 Selective adenosine receptor compounds ZA902282B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33040089A 1989-03-29 1989-03-29

Publications (1)

Publication Number Publication Date
ZA902282B true ZA902282B (en) 1990-12-28

Family

ID=23289598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902282A ZA902282B (en) 1989-03-29 1990-03-23 Selective adenosine receptor compounds

Country Status (18)

Country Link
EP (1) EP0390111B1 (zh)
JP (1) JP3014000B2 (zh)
KR (1) KR0150635B1 (zh)
CN (1) CN1029972C (zh)
AR (1) AR245720A1 (zh)
AT (1) ATE111466T1 (zh)
AU (1) AU623755B2 (zh)
CA (1) CA2013381C (zh)
DE (1) DE69012388T2 (zh)
ES (1) ES2063851T3 (zh)
FI (1) FI95133C (zh)
HU (1) HU203349B (zh)
IE (1) IE63545B1 (zh)
IL (1) IL93893A (zh)
NO (1) NO173997C (zh)
NZ (1) NZ233077A (zh)
PT (1) PT93589B (zh)
ZA (1) ZA902282B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195739T1 (de) * 1989-10-20 2000-09-15 Kyowa Hakko Kogyo Kk Kondensierte purinderivate
IL98559A0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
DE19629378A1 (de) * 1996-07-20 1998-01-29 Boehringer Ingelheim Kg Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2001047931A1 (fr) * 1999-12-24 2001-07-05 Kyowa Hakko Kogyo Co., Ltd. Derives de purine fondue

Also Published As

Publication number Publication date
CN1029972C (zh) 1995-10-11
FI95133B (fi) 1995-09-15
AR245720A1 (es) 1994-02-28
DE69012388D1 (de) 1994-10-20
NZ233077A (en) 1992-12-23
HU203349B (en) 1991-07-29
HU901857D0 (en) 1990-08-28
IE63545B1 (en) 1995-05-17
NO173997C (no) 1994-03-02
CA2013381C (en) 2000-06-20
EP0390111A3 (en) 1991-05-08
FI95133C (fi) 1995-12-27
CA2013381A1 (en) 1990-09-29
ATE111466T1 (de) 1994-09-15
NO901424D0 (no) 1990-03-28
HUT54160A (en) 1991-01-28
IE901142L (en) 1990-09-29
JP3014000B2 (ja) 2000-02-28
KR0150635B1 (ko) 1998-10-15
AU623755B2 (en) 1992-05-21
KR900014390A (ko) 1990-10-23
JPH02289574A (ja) 1990-11-29
FI901550A0 (fi) 1990-03-28
PT93589A (pt) 1990-11-20
ES2063851T3 (es) 1995-01-16
EP0390111B1 (en) 1994-09-14
EP0390111A2 (en) 1990-10-03
IL93893A (en) 1994-07-31
DE69012388T2 (de) 1995-04-27
NO173997B (no) 1993-11-22
NO901424L (no) 1990-10-01
PT93589B (pt) 1996-06-28
AU5218290A (en) 1990-10-04
CN1045974A (zh) 1990-10-10
IL93893A0 (en) 1990-12-23

Similar Documents

Publication Publication Date Title
ZA89440B (en) Dideoxydidehydrocarbocyclic nucleosides
GB2135311B (en) Novel xanthine-type adenosine receptor antagonists
AP8800099A0 (en) Therapeuric acyclic nucleosides
GB2217320B (en) Dideoxydidehydrocarbocyclic nucleosides
AU5967390A (en) D-propranolol as a selective adenosine antagonist
ZA912038B (en) Selective adenosine receptor agents
GB2223579B (en) Verocytotoxin receptor assay
OA09697A (en) Nucleoside derivatives
EP0493434A4 (en) Tsh receptor
ZA89671B (en) Macrolide compounds
ZA902282B (en) Selective adenosine receptor compounds
EP0407816A3 (en) Base modified nucleosides
EP0450102A4 (en) Nucleoside derivative
GB9110987D0 (en) Dideoxydidehydrocarboxyclic nucleosides
GB8916323D0 (en) Nucleosides
IE892332L (en) Nucleosides
GB8909205D0 (en) Multipletool lathes
GB8925037D0 (en) Nucleoside derivatives
GB8925039D0 (en) Nucleoside derivatives
IE890947L (en) Producing dideoxy-didehydro nucleosides
ZA903647B (en) Nucleoside analogs
IE882786L (en) Milbemycin type antiparasitic agents
IE891766L (en) Avermectins
IE891036L (en) Fluorophonate nucleotide derivatives
IE882741L (en) Macrolide compounds